Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Multiple reaction monitoring to identify site-specific troponin I phosphorylated residues in the failing human heart.

Zhang P, Kirk JA, Ji W, dos Remedios CG, Kass DA, Van Eyk JE, Murphy AM.

Circulation. 2012 Oct 9;126(15):1828-37. doi: 10.1161/CIRCULATIONAHA.112.096388. Epub 2012 Sep 12.

2.

Additional PKA phosphorylation sites in human cardiac troponin I.

Ward DG, Ashton PR, Trayer HR, Trayer IP.

Eur J Biochem. 2001 Jan;268(1):179-85.

4.

Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C.

Li MX, Wang X, Lindhout DA, Buscemi N, Van Eyk JE, Sykes BD.

Biochemistry. 2003 Dec 16;42(49):14460-8.

PMID:
14661957
5.

NMR and mutagenesis studies on the phosphorylation region of human cardiac troponin I.

Ward DG, Brewer SM, Gallon CE, Gao Y, Levine BA, Trayer IP.

Biochemistry. 2004 May 18;43(19):5772-81.

PMID:
15134451
6.

Augmented phosphorylation of cardiac troponin I in hypertensive heart failure.

Dong X, Sumandea CA, Chen YC, Garcia-Cazarin ML, Zhang J, Balke CW, Sumandea MP, Ge Y.

J Biol Chem. 2012 Jan 6;287(2):848-57. doi: 10.1074/jbc.M111.293258. Epub 2011 Nov 3.

7.

Effects of T142 phosphorylation and mutation R145G on the interaction of the inhibitory region of human cardiac troponin I with the C-domain of human cardiac troponin C.

Lindhout DA, Li MX, Schieve D, Sykes BD.

Biochemistry. 2002 Jun 11;41(23):7267-74. Erratum in: Biochemistry. 2003 Jan 14;42(1):238..

PMID:
12044157
8.

Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins.

van der Velden J, Papp Z, Zaremba R, Boontje NM, de Jong JW, Owen VJ, Burton PB, Goldmann P, Jaquet K, Stienen GJ.

Cardiovasc Res. 2003 Jan;57(1):37-47.

PMID:
12504812
9.

Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure.

Zhang J, Guy MJ, Norman HS, Chen YC, Xu Q, Dong X, Guner H, Wang S, Kohmoto T, Young KH, Moss RL, Ge Y.

J Proteome Res. 2011 Sep 2;10(9):4054-65. doi: 10.1021/pr200258m. Epub 2011 Jul 28.

10.

PKCα-specific phosphorylation of the troponin complex in human myocardium: a functional and proteomics analysis.

Kooij V, Zhang P, Piersma SR, Sequeira V, Boontje NM, Wijnker PJ, Jiménez CR, Jaquet KE, dos Remedios C, Murphy AM, Van Eyk JE, van der Velden J, Stienen GJ.

PLoS One. 2013 Oct 7;8(10):e74847. doi: 10.1371/journal.pone.0074847. eCollection 2013.

11.

Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling.

DeMazumder D, Kass DA, O'Rourke B, Tomaselli GF.

Circ Res. 2015 May 8;116(10):1691-9. doi: 10.1161/CIRCRESAHA.116.305268. Epub 2015 Mar 2.

12.

Interventricular differences in myofilament function in experimental congestive heart failure.

Belin RJ, Sumandea MP, Sievert GA, Harvey LA, Geenen DL, Solaro RJ, de Tombe PP.

Pflugers Arch. 2011 Dec;462(6):795-809. doi: 10.1007/s00424-011-1024-4. Epub 2011 Sep 17.

13.

Phosphorylation of cardiac troponin I by mammalian sterile 20-like kinase 1.

You B, Yan G, Zhang Z, Yan L, Li J, Ge Q, Jin JP, Sun J.

Biochem J. 2009 Feb 15;418(1):93-101. doi: 10.1042/BJ20081340.

14.

The interaction of the bisphosphorylated N-terminal arm of cardiac troponin I-A 31P-NMR study.

Schmidtmann A, Lohmann K, Jaquet K.

FEBS Lett. 2002 Feb 27;513(2-3):289-93.

15.

Characterization of the cardiac myosin binding protein-C phosphoproteome in healthy and failing human hearts.

Kooij V, Holewinski RJ, Murphy AM, Van Eyk JE.

J Mol Cell Cardiol. 2013 Jul;60:116-20. doi: 10.1016/j.yjmcc.2013.04.012. Epub 2013 Apr 22.

16.

Characterization of the interaction between the N-terminal extension of human cardiac troponin I and troponin C.

Ward DG, Brewer SM, Calvert MJ, Gallon CE, Gao Y, Trayer IP.

Biochemistry. 2004 Apr 6;43(13):4020-7.

PMID:
15049709
17.

Computational studies of the effect of the S23D/S24D troponin I mutation on cardiac troponin structural dynamics.

Cheng Y, Lindert S, Kekenes-Huskey P, Rao VS, Solaro RJ, Rosevear PR, Amaro R, McCulloch AD, McCammon JA, Regnier M.

Biophys J. 2014 Oct 7;107(7):1675-85. doi: 10.1016/j.bpj.2014.08.008.

18.

Troponin I phosphorylation in the normal and failing adult human heart.

Bodor GS, Oakeley AE, Allen PD, Crimmins DL, Ladenson JH, Anderson PA.

Circulation. 1997 Sep 2;96(5):1495-500.

19.

Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCepsilon phosphorylation.

Scruggs SB, Walker LA, Lyu T, Geenen DL, Solaro RJ, Buttrick PM, Goldspink PH.

J Mol Cell Cardiol. 2006 Apr;40(4):465-73. Epub 2006 Jan 30.

PMID:
16445938
20.

Unraveling molecular complexity of phosphorylated human cardiac troponin I by top down electron capture dissociation/electron transfer dissociation mass spectrometry.

Zabrouskov V, Ge Y, Schwartz J, Walker JW.

Mol Cell Proteomics. 2008 Oct;7(10):1838-49. doi: 10.1074/mcp.M700524-MCP200. Epub 2008 Apr 28.

Supplemental Content

Support Center